236 related articles for article (PubMed ID: 36256911)
1. Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/
Attarbaschi A; Möricke A; Harrison CJ; Mann G; Baruchel A; De Moerloose B; Conter V; Devidas M; Elitzur S; Escherich G; Hunger SP; Horibe K; Manabe A; Loh ML; Pieters R; Schmiegelow K; Silverman LB; Stary J; Vora A; Pui CH; Schrappe M; Zimmermann M;
J Clin Oncol; 2023 Mar; 41(7):1404-1422. PubMed ID: 36256911
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the characteristics of primary acute myeloid leukemia with 11q23/KMT2A rearrangements in ninety patients].
Li Y; Wang Y; Wang Z; Feng L; Gao L; Shi Y; Dang H; He Q; Qin Y; Jiang Q; Jiang H; Huang X; Lai Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Dec; 40(12):1472-1477. PubMed ID: 37994126
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia.
Bai L; Cheng YF; Lu AD; Suo P; Wang Y; Zuo YX; Yan CH; Wu J; Jia YP; Sun YQ; Chen YH; Chen H; Liu KY; Han W; Xu LP; Wang JB; Tang XF; Chen HR; Zhang LP; Huang XJ
Leuk Res; 2020 Apr; 91():106333. PubMed ID: 32109757
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.
Liu J; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Cheng YF; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD
Ann Hematol; 2021 May; 100(5):1267-1281. PubMed ID: 33712867
[TBL] [Abstract][Full Text] [Related]
5. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements.
Yuen KY; Liu Y; Zhou YZ; Wang Y; Zhou DH; Fang JP; Xu LH
Cancer Med; 2023 Jan; 12(2):1418-1430. PubMed ID: 35833755
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT.
Esteve J; Giebel S; Labopin M; Czerw T; Wu D; Volin L; Socié G; Yakoub-Agha I; Maertens J; Cornelissen JJ; Pigneux A; Shimoni A; Schwerdtfeger R; Labussière-Wallet H; Russell N; Schattenberg A; Chevallier P; Koza V; Foà R; Schmid C; Peric Z; Mohty M; Nagler A
Leukemia; 2021 Aug; 35(8):2232-2242. PubMed ID: 33542481
[TBL] [Abstract][Full Text] [Related]
7. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.
Balgobind BV; Raimondi SC; Harbott J; Zimmermann M; Alonzo TA; Auvrignon A; Beverloo HB; Chang M; Creutzig U; Dworzak MN; Forestier E; Gibson B; Hasle H; Harrison CJ; Heerema NA; Kaspers GJ; Leszl A; Litvinko N; Nigro LL; Morimoto A; Perot C; Pieters R; Reinhardt D; Rubnitz JE; Smith FO; Stary J; Stasevich I; Strehl S; Taga T; Tomizawa D; Webb D; Zemanova Z; Zwaan CM; van den Heuvel-Eibrink MM
Blood; 2009 Sep; 114(12):2489-96. PubMed ID: 19528532
[TBL] [Abstract][Full Text] [Related]
8. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
10. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.
Pui CH; Gaynon PS; Boyett JM; Chessells JM; Baruchel A; Kamps W; Silverman LB; Biondi A; Harms DO; Vilmer E; Schrappe M; Camitta B
Lancet; 2002 Jun; 359(9321):1909-15. PubMed ID: 12057554
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].
Luo L; Jiao Y; Yang P; Li Y; Huang WY; Ke XY; Zou DH; Jing HM
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):388-394. PubMed ID: 37550188
[No Abstract] [Full Text] [Related]
12. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not
Zuo W; Wang SA; DiNardo C; Yabe M; Li S; Medeiros LJ; Tang G
J Clin Pathol; 2017 Mar; 70(3):244-249. PubMed ID: 27496968
[TBL] [Abstract][Full Text] [Related]
13. Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission.
Zhang Y; Bai L; Cheng Y; Lu A; Wang Y; Wu J; Zhang X; Zuo Y; Xu L; Jia Y; Huang X; Zhang L
Chin Med J (Engl); 2022 Apr; 135(8):940-949. PubMed ID: 35730372
[TBL] [Abstract][Full Text] [Related]
14. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience.
Richard-Carpentier G; Kantarjian HM; Tang G; Yin CC; Khoury JD; Issa GC; Haddad F; Jain N; Ravandi F; Short NJ; DiNardo CD; Takahashi K; Konopleva MY; Daver NG; Kadia T; Garcia-Manero G; Garris R; O'Brien S; Jabbour E
Blood Adv; 2021 Dec; 5(23):5415-5419. PubMed ID: 34525185
[TBL] [Abstract][Full Text] [Related]
16. Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements.
Wen J; Zhou M; Shen Y; Long Y; Guo Y; Song L; Xiao J
BMC Cancer; 2022 Aug; 22(1):859. PubMed ID: 35933338
[TBL] [Abstract][Full Text] [Related]
17. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
[TBL] [Abstract][Full Text] [Related]
18. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group.
Heerema NA; Sather HN; Ge J; Arthur DC; Hilden JM; Trigg ME; Reaman GH
Leukemia; 1999 May; 13(5):679-86. PubMed ID: 10374870
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene-rearranged acute lymphoblastic leukemia.
Takachi T; Watanabe T; Miyamura T; Moriya Saito A; Deguchi T; Hori T; Yamada T; Ohmori S; Haba M; Aoki Y; Ishimaru S; Sasaki S; Ohshima J; Iguchi A; Takahashi Y; Hyakuna N; Manabe A; Horibe K; Ishii E; Koh K; Tomizawa D
Blood Adv; 2021 Oct; 5(19):3891-3899. PubMed ID: 34500465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
